Chlortalidone
Clinical data | |
---|---|
Trade names | Hygroton, Thalitone, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682342 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Thiazide-like diuretic |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 75% |
Elimination half-life | 40 hours |
Excretion | Kidney |
Identifiers | |
| |
JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Chlortalidone, also known as chlorthalidone, is a
Common adverse effects include
Chlortalidone was patented in 1957 and came into medical use in 1960.
Medical use
High blood pressure
Chlortalidone is considered a first-line medication for treatment
Trials of chlortalidone for high blood pressure found that lower doses of chlortalidone (e.g., 12.5 mg daily in ALLHAT study) had maximal blood pressure lowering effect and that higher doses did not lower it more. Chlortalidone and other thiazide diuretics are effective for lowering high blood pressure in persons with chronic kidney disease, although the risk of adverse effects is higher.[18][19][20] [21]
Left ventricular hypertrophy
Chlortalidone is used to treat
Swelling
Chlortalidone reduces
Bone fracture prevention
Chlortalidone decreases mineral bone loss by promoting calcium retention by the kidney, and by directly stimulating osteoblast differentiation and bone mineral formation.[26] A Cochrane review found tentative evidence that thiazide exposure was associated with a reduced risk of hip fracture.[27] A secondary analysis of data from the ALLHAT study found that chlortalidone reduced risk of hip and pelvis fracture.[28]
Kidney stone prevention
Chlortalidone reduces the amount of calcium excreted in urine, reducing the risk of
Ménière's disease
Chlortalidone reduces the endolymph volume which reduces the hydrostatic pressure in the inner ear chambers; elevated endolymph pressure in the inner ear is thought to be the cause of Ménière's disease or ’Endolymphatic hydrops.’ Synthesis of evidence from multiple small, low-quality studies indicates that chlortalidone or other thiazide diuretics are effective for Ménière's Disease.[32]
Diabetes insipidus
Chlortalidone (or other thiazide medication) is a key component of treatment of
Adverse effects
Some reviews have found a similar risk as hydrochlorothiazide,[8][9] while other reviews found a higher risk of side effects.[1][10]
- Hypokalemia (low blood potassium) occurs occasionally; the risk of hypokalemia is higher in persons who are magnesium deficient[34]
- Hypomagnesemia (low blood magnesium) a review of four clinical trials found that low blood magnesium occurred in 20% of persons within a few weeks of beginning treatment with 50 mg of chlortalidone daily.[35]The risk of chlortalidone-associated hypomagnesemia is higher in persons with diabetes mellitus who have low dietary magnesium intake.
- SLCO2A1 associated with elevated urinary PGE2 and inappropriately low plasma ADH levels in the setting of low plasma osmolality.[39] Thiazide-associated hyponatremia is often more severe than loop diuretic-associated hyponatremia because the predominant action of thiazides occurs late in the tubular flow, reducing opportunity to apply additional corrective action further along the tubule.[40]
- Hypercalcemia (high blood calcium level) can occur in normal persons exposed to chlortalidone but is more likely to occur when persons with sub-clinical hyperparathyroidism are exposed to chlortalidone.[41]
- Hyperuricemia, high levels of uric acid in the blood
- Hyperglycemia, high blood sugar is more common in persons who are magnesium deficient
- Hyperlipidemia, high cholesterol and triglycerides
- Headache
- Nausea/vomiting
- Photosensitivity increased susceptibility to sunburn of skin with sun exposure
- Photoonycholysis detachment of nails from nailbed with sun exposure[42]
- Weight gain
- Gout; approximately doubles the risk[43]
- Pancreatitis
The frequency and severity of these adverse effects is much reduced when chlortalidone is used at lower doses (e.g., 12.5 mg per day).
Mechanism of action
Chlortalidone reduces reabsorption of sodium and chloride primarily through inhibition of the Na+/Cl− symporter in the apical membrane of distal convoluted tubule cells in the kidney.[44] Although chlortalidone is often referred to as a "thiazide-like" diuretic, it is unlike thiazide diuretics in that, in addition to its inhibition of the Na+/Cl− symporter, it also strongly inhibits multiple isoforms of carbonic anhydrase.[45] Some of chlortalidone's diuretic effect is also due to this inhibition of carbonic anhydrase in the proximal tubule.[46] Chronic exposure to chlortalidone decreases the glomerular filtration rate. Chlortalidone's diuretic effect is diminished in persons with kidney impairment. By increasing the delivery of sodium to the distal renal tubule, chlortalidone indirectly increases potassium excretion via the sodium-potassium exchange mechanism (i.e. apical ROMK/Na channels coupled with basolateral Na+/K ATPases). This can result in a low blood concentration of potassium and chloride as well as a mild metabolic alkalosis; however, the diuretic effect of chlortalidone is not affected by the acid-base balance of the person being treated.
There is uncertainty about the mechanism of the blood pressure-lowering effect that occurs during chronic exposure to chlortalidone.
Pharmacokinetics
Chlortalidone is slowly absorbed from the gastrointestinal tract after oral ingestion. It has a long half-life and therefore a prolonged diuretic action, which results in continued diuretic effects despite a skipped dose. This prolonged action of chlortalidone despite missing doses may account for the higher efficacy of chlortalidone compared to the shorter half-life medication, hydrochlorothiazide. Chlortalidone is eliminated from the body mostly by the kidney, as unchanged drug. Thus, in persons with diminished kidney function, the clearance of chlortalidone is reduced and the elimination half-life is increased.[48]
As with other thiazide diuretics, chlortalidone crosses the placenta and is excreted in breast milk.[49] Chlortalidone may suppress lactation, and has been used for this indication. Due to its long half-life, chlortalidone may accumulate in newborns via breast milk, despite receiving only about 6% of the maternal weight-adjusted dose.[50]
Chemistry
Chlortalidone is in the sulfamoylbenzamide class. As it lacks the
Chlortalidone is the official name of the medication according to the (
Society and culture
Chlortalidone is banned for some sports (including
References
- ^ PMID 30920924.
A long-acting thiazide-like diuretic, specifically chlorthalidone, if available, is recommended over hydrochlorothiazide (HCTZ) given its superior efficacy and clear benefit demonstrated in multiple outcome studies of hypertension.
- ^ a b c d e f g h i j "Chlorthalidone Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 18 April 2019.
- ^ ISBN 978-0-85711-338-2.
- PMID 35404993.
- S2CID 231649367.
- PMID 27168745.)
{{cite journal}}
: CS1 maint: DOI inactive as of March 2024 (link - ^ "Chlorthalidone" (PDF). FDA. Retrieved 27 March 2020.
- ^ PMID 31595024.
- ^ PMID 30251403.
- ^ PMID 26760416.
- ISBN 978-3-527-60749-5.
- hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Chlorthalidone - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
- PMID 26049382.
- PMID 31595024.
- PMID 29357392.
- S2CID 49650101.
- S2CID 6108618.
- PMID 24869750.
- PMID 30425103.
thiazides either alone or in combination with a loop diuretic in advanced CKD, and all show some degree of efficacy, whether for hypertension or diuresis
- PMID 30251403.
- S2CID 3423953.
- PMID 27324677.
- PMID 15952439.
- PMID 17656470.
- S2CID 28866803.
- PMID 27893045.
- S2CID 2514178.
- PMID 23546565.
- S2CID 10227907.
- S2CID 24741244.
- S2CID 33533827.
- PMID 29387426.
- PMID 11076102.
- PMID 2046107.
- PMID 25139696.
- PMID 24811554.
- PMID 28783044.
- ISBN 978-3-318-06383-7.
- PMID 26751196.
- ISBN 978-3-319-65647-2.
- PMID 29976236.
- PMID 19474192.
- PMID 20625074.
- PMID 411910.
- PMID 26874237.
- ^ ISBN 978-0-12-260814-8.
- S2CID 22930934.
- PMID 30000622. NBK501562. Retrieved 13 December 2018.
- ^ National Center for Biotechnology Information. PubChem Compound Database; CID=2732, "Chlorthalidone". PubChem. U.S. National Library of Medicine.
- PMID 20718736.
- ^ "Yasir Shah provisionally suspended after failed drugs test". BBC News. 27 December 2015.